Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress

Stock Information for Apollomics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Apollomics Inc.

Apollomics Inc. Announces $2.0 Million Bridge Financing
Apollomics Reports First Half 2025 Financial Results
Apollomics Announces Settlement of Cayman Litigation
Apollomics Announces Changes to its Board of Directors and Composition of Committees
Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation
Nasdaq Resumes Trading in Apollomics Inc.
Apollomics, Inc. Company Operational Continuity Update
Nasdaq Halts Apollomics Inc., Ltd.

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.